Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventory Turnover measures how fast the company turns over its inventory within a year.
ASKA Pharmaceutical Holdings Co's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.30.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ASKA Pharmaceutical Holdings Co's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.77.
ASKA Pharmaceutical Holdings Co (TSE:4886) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
ASKA Pharmaceutical Holdings Co's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ASKA Pharmaceutical Holdings Co's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
ASKA Pharmaceutical Holdings Co Days Inventory Related Terms
ASKA Pharmaceutical Holdings Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, ASKA Pharmaceutical Holdings Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASKA Pharmaceutical Holdings Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ASKA Pharmaceutical Holdings Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where ASKA Pharmaceutical Holdings Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co (TSE:4886) has a Days Inventory of 304.15 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. This is 41% above median its historical median of 216.02. Over the past decade, ASKA Pharmaceutical Holdings Co's Days Inventory has ranged from 181.68 to 276.09. According to the industry distribution chart, ASKA Pharmaceutical Holdings Co ranks #744 out of 921 companies in the Drug Manufacturers industry, placing it in the top 80.8%.
Is ASKA Pharmaceutical Holdings Co's Days Inventory too high?
ASKA Pharmaceutical Holdings Co's current Days Inventory of 304.15 is 41% above median its 10-year median of 216.02. Over the past 10 years, this metric has ranged from a low of 181.68 to a high of 276.09. The Drug Manufacturers industry median Days Inventory is 164.48. ASKA Pharmaceutical Holdings Co's value of 304.15 is 84.9% above this industry median. Based on the distribution chart, ASKA Pharmaceutical Holdings Co ranks #744 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, ASKA Pharmaceutical Holdings Co has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ASKA Pharmaceutical Holdings Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ASKA Pharmaceutical Holdings Co ranks #744 out of 921 companies for Days Inventory. This places ASKA Pharmaceutical Holdings Co in the lower half of its industry. The industry median Days Inventory is 164.48. ASKA Pharmaceutical Holdings Co's value of 304.15 is 84.9% above this benchmark. Historically, ASKA Pharmaceutical Holdings Co's own Days Inventory has ranged from 181.68 to 276.09 over the past decade. While the company's 10-year median is 216.02 vs. the industry median of 164.48, ASKA Pharmaceutical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ASKA Pharmaceutical Holdings Co's current Days Inventory of 304.15 is 84.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASKA Pharmaceutical Holdings Co's current Days Inventory is 304.15, which is 41% above median its own 10-year median of 216.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASKA Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co (TSE:4886) is currently considered Fairly Valued. The stock's GF Value™ is 円2,402.52, compared to a current price of 円2,244.00 — trading 6.6% below its estimated fair value. The current Days Inventory is 304.15, which is 41% above median its 10-year median of 216.02 and 84.9% above the Drug Manufacturers industry median of 164.48. ASKA Pharmaceutical Holdings Co's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For ASKA Pharmaceutical Holdings Co (TSE:4886), the current Days Inventory is 304.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ASKA Pharmaceutical Holdings Co (TSE:4886) Overvalued in 2026?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of 円2,244.00 is trading 6.6% below its estimated GF Value™ of 円2,402.52.
GuruFocus considers ASKA Pharmaceutical Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4886:
Days Inventory: 304.15 (41% above median its 10-year median of 216.02)
GF Value™: 円2,402.52 vs. price of 円2,244.00 (6.6% below fair value)
Industry Position: 84.9% above the Drug Manufacturers median (#744 of 921)
No single metric tells the full story. See the TSE:4886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ASKA Pharmaceutical Holdings Co Business Description
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and other related operations.
61GF Score
Get the complete analysis for TSE:4886
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4886 has been successfully added to your 
